Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Lymphoid 1

Conditions

Lymphoma, Follicular 1Depressive Disorder, Major 1Depressive Disorder 1

Interventions

Rituximab 1401Cyclophosphamide 1306Vincristine 668Doxorubicin 587Etoposide 527Prednisone 511Cytarabine 486fludarabine 470Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 261ibrutinib 258obinutuzumab 236Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Antidepressive Agents × Lymphoid × Clear all
NCT05701345 2024-11-04

Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder

Omni C&S

Phase NA Completed
162 enrolled
Lymphoid

Depressive Disorder, Major, Depressive Disorder, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡